REVANCE THERAPEUTICS INCREVANCE THERAPEUTICS INCREVANCE THERAPEUTICS INC

REVANCE THERAPEUTICS INC

No trades
See on Supercharts

Price target

13.850.00 0.00%
The 11 analysts offering 1 year price forecasts for RTI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 12 analysts giving stock ratings to RTI in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

RTI EPS for the last quarter is −0.45 EUR despite the estimation of −0.59 EUR. In the next quarter EPS is expected to reach −0.43 EUR. Track more of REVANCE THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter REVANCE THERAPEUTICS INC revenue is expected to reach ‪52.27 M‬ EUR. Check out REVANCE THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, RTI price target is 13.85 EUR with a max estimate of 27.88 EUR and a min estimate of 5.58 EUR. Check if this forecast comes true in a year, meanwhile watch REVANCE THERAPEUTICS INC stock price chart and keep track of the current situation with RTI news and stock market news.
We've gathered opinions of 12 analysts rating RTI stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.